BR112012026314A2 - biomarcador para função renal em pacientes com diabetes do tipo 2 - Google Patents

biomarcador para função renal em pacientes com diabetes do tipo 2

Info

Publication number
BR112012026314A2
BR112012026314A2 BR112012026314A BR112012026314A BR112012026314A2 BR 112012026314 A2 BR112012026314 A2 BR 112012026314A2 BR 112012026314 A BR112012026314 A BR 112012026314A BR 112012026314 A BR112012026314 A BR 112012026314A BR 112012026314 A2 BR112012026314 A2 BR 112012026314A2
Authority
BR
Brazil
Prior art keywords
patients
renal function
biomarker
type
diabetes
Prior art date
Application number
BR112012026314A
Other languages
English (en)
Inventor
Chia Ke Seng
Holthofer Harry
Ng Peng Keat Daniel
Tai Bee Choc
Original Assignee
Univ Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Singapore filed Critical Univ Singapore
Publication of BR112012026314A2 publication Critical patent/BR112012026314A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J49/00—Particle spectrometers or separator tubes
    • H01J49/004—Combinations of spectrometers, tandem spectrometers, e.g. MS/MS, MSn
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

biomarcador para função renal em pacientes com diabetes do tipo 2 a invenção provê kits e métodos para o diagnóstico, prognóstico e tratamento de função renal reduzida em pacientes, tais como pacientes diabéticos. os métodos incluem uma etapa de detecção de um ou mais produtos da degradação de nefrina em uma amostra proveniente de um indivíduo, tal como uma amostra de urina.
BR112012026314A 2010-04-12 2011-04-12 biomarcador para função renal em pacientes com diabetes do tipo 2 BR112012026314A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32294910P 2010-04-12 2010-04-12
PCT/SG2011/000143 WO2011129768A1 (en) 2010-04-12 2011-04-12 A biomarker for renal function in patients with type 2 diabetes

Publications (1)

Publication Number Publication Date
BR112012026314A2 true BR112012026314A2 (pt) 2016-11-29

Family

ID=44798908

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012026314A BR112012026314A2 (pt) 2010-04-12 2011-04-12 biomarcador para função renal em pacientes com diabetes do tipo 2

Country Status (6)

Country Link
US (1) US20130101578A1 (pt)
CN (1) CN103189749A (pt)
BR (1) BR112012026314A2 (pt)
CA (1) CA2796384A1 (pt)
SG (1) SG184571A1 (pt)
WO (1) WO2011129768A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104849466A (zh) * 2014-02-14 2015-08-19 张曼 尿液玻璃体结合蛋白在2型糖尿病合并早期肾损伤诊治中的应用
CN110927278B (zh) * 2019-12-09 2022-07-01 湖南九典制药股份有限公司 改进的盐酸咪达普利有关物质的分离方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI991369A0 (fi) * 1999-06-15 1999-06-15 Harry Holthoefer Haiman ja munuaiskeräsen ilmentäminen liukoisten proteiinimolekyylien käyttö
EP1336845B1 (en) * 2000-10-27 2013-03-27 DENKA SEIKEN Co., Ltd. Method of diagnosing nephropathy
US20070254027A1 (en) * 2006-04-28 2007-11-01 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness

Also Published As

Publication number Publication date
CA2796384A1 (en) 2011-10-20
SG184571A1 (en) 2012-11-29
WO2011129768A1 (en) 2011-10-20
CN103189749A (zh) 2013-07-03
US20130101578A1 (en) 2013-04-25

Similar Documents

Publication Publication Date Title
BR112014031365A2 (pt) métodos de detectar doenças ou condições
BR112013010023A2 (pt) algoritimo aperfeiçoado para a detecção de diabetes
WO2012031008A3 (en) Cancer-related biological materials in microvesicles
BR112012012513A2 (pt) método para diagnosticar síndrome do intestino irritável em um paciente, método para monitorar a progressão ou regressão da síndrome do intestino irritável em um paciente, e para designar uma terapia contra síndrome do intestino irritável a um paciente em necessidade do mesmo
BR112013004750A2 (pt) derivados de quinolina e quinoxalina como inibidores da cinase
WO2013107459A3 (en) Microrna for diagnosis of pancreatic cancer and/or prognosis of patients with pancreatic cancer by blood samples
EP4303584A3 (en) Methods for detecting signatures of disease or conditions in bodily fluids
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
MX2010013876A (es) Agonistas de arilo grpr119 y sus usos .
BR112012030587A2 (pt) métodos para diagnóstico de câncer pancreático, para identificar se um indivíduo precisa ou não de uma terapia contra câncer pancreático e para determinar se uma terapia contra câncer pancreático obtém sucesso, dispositivo para diagnóstico de câncer pancreático e uso de pelo menos um biomarcador
IN2012DN02710A (pt)
WO2011135459A3 (en) Methods and devices for predicting treatment efficacy
WO2010099342A3 (en) Methods of detecting lung cancer
MY175351A (en) Method and kit for measurement of nk cell activity
BR112013003160A2 (pt) tratamento de diabetes com células precursoras endócrinas pancráticas
WO2012017430A3 (en) Microrna patterns for the diagnosis, prognosis and treatment of melanoma
WO2012078288A3 (en) Methods of determining risk of adverse outcomes in acute myeloid leukemia
ES2530743T3 (es) Método in vitro y kit para el pronóstico o predicción de la respuesta por parte de pacientes con artritis reumatoide al tratamiento con agentes bloqueantes del factor TNFalfa
WO2012101219A3 (en) Complex mirna sets as novel biomarkers for lung diseases
WO2012074882A3 (en) Phagocytic activity as a marker of synucleinopathic disease
BR112012026314A2 (pt) biomarcador para função renal em pacientes com diabetes do tipo 2
GB201114909D0 (en) Biomarkers for lysosomal storage disorders
BR112014008311A2 (pt) método de prognóstico para diabetes
GB201018312D0 (en) Metagene expression signature for prognosis of breast cancer patients
UA78641U (ru) Способ прогнозирования тяжести больных острым панкреатитом

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]